Policy Horizons Canada, in collaboration with SynBio Canada, is launching a series of webinars on the convergence of biological and digital systems. The webinars provide an overview of disruptive innovations in the field of biodigital, and explore their potential implications.
The content discussed in the biodigital webinar series is part of Policy Horizons Canada’s ongoing foresight work. The content, discussion, and presentations do not represent the views of the Government of Canada.
We have Google folders for each of the Webinars. This will facilitate sharing useful information between us.
Please send us the documents you would like to share with webinar attendees ahead of time so we may upload them to the proper folder.
We ask that attendees not record or take screenshots of any part of the webinar without the permission of the presenters and Policy Horizons Canada.
We may record some webinars, but only if we have the explicit permission and consent of the presenter.
All recordings will be available on the Google folder in the week following the presentation.
Rules of Engagement
We do not attempt to predict the future, but rather explore it.
We invite the exploration of all possibilities.
Please do not hesitate to share your thoughts; there are no wrong answers.
We are not here to debate the plausibility but rather explore many potential implications, challenges, opportunities and scenarios.
All suggested outcomes will be treated as plausible, and we will strongly discourage debates on the likelihood of their occurence.
Be mindful that we are working online. Policy Horizons and SynBio Canada are not responsible for external problems that may arise, such as internet connectivity or uninvited individuals attending the session. We will do our best to avoid any issues within our control.
Attending these webinars requires registration. We will provide a link to register for each webinar session. Following registration, we will provide a Zoom link for each registered participant. Participants may share the registration link with their network if they would like to encourage others to register and participate.
As part of the Federal government, Horizons does not endorse comments or content shared via the webinars, nor does it engage the government of Canada in any way. This also applies to the content generated during foresight exercises such as influence cascade diagrams.
We’re kicking off the 2021 biodigital webinars with an exploration of biodesign, bio-fashion and bio-art! Join us to discover how designers and artists are experimenting with innovations in genetic engineering, DNA sequencing, DNA writing, and 3D bio-printing.
Veena Vijayakumar, Program Manager of Biodesign Challenge
Dr. Karen Hogan, CEO and Cofounder at Biorealize, Inc
William Myers, curator, writer (Biodesign published in 2018, Bio Art: Altered Realities published in 2015), and teacher based in Amsterdam
Dr. Jennifer Willet, Director of INCUBATOR art lab and a Canada Research Chair in Art, Science and Ecology at the University of Windsor
Derek Jacoby, Victoria Makerspace Kevin Chen, Bricobio, Hyasynth
Session 4: Microbiome
June 4, 2020, 2:00pm – 3:30pm EDT
Gregor Reid, Seed Trevor Charles, Metagenom Bio
Session 5: Biodigital in a Post-COVID World
June 18, 2020
Dr. David Edgell, Professor, Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University Dr. Pérez Escudero, Crowdfight Covid-19
Session 6: SynBio Education
July 2, 2020
Julie Legault, Founder, Amino Labs Patrick Diep, Program Director at The Canadian Synthetic Biology Education Research Group
Session 7: The Ethics of Gene Editing
September 17th 2020, 10:00-11:30 am EST
Dr. Francoise Baylis, Research Professor, Impact Ethics, Faculty of Medicine, Dalhousie University
Dr. Vardit Ravitsky, Professor at the Bioethics Programs within the Department of Social and Preventive Medicine of the School of Public Health at the University of Montreal
Session 8: The Bioeconomy
October 1st 2020, 2:00 pm – 3:30 pm EST
Jeff Passmore, CEO Passmore Group
Christopher Bush, Agricultural Centre of Excellence in Sustainability
Session 9: AI/Machine learning & Automation for Engineering biology
October 15th 2020, 2:00 pm – 3:30 pm EST
Dr.Richard Fox, Co-founder, Infinome Biosciences
Naman Agarwal, Director of Business Operations, ProteinQure
Session 10: Gene Drives
October 29th 2020, 2:00pm – 3:30pm EST
Dr. Natalie Kofler, Founder, Editing Nature
Dr. Todd Kuiken, Environmental scientist and Senior Research Scholar with the Genetic Engineering and Society Center at North Carolina State University
Session 11: Indigenous Perspectives on the Biodigital
November 12th 2020, 2:00pm – 3:30pm EST
Suzanne Brant, President & CEO, First Nations Technical Institute (FNTI)
Keith Williams, Director of Research and Social Innovation, First Nations Technical Institute (FNTI)
Session 12: Next Generation Biomanufacturing for the Bio-Revolution: An International Opportunity
December 3 2020, 2:00pm – 3:30pm EST
Ontario Genomics is pleased to partner with Policy Horizons Canada and SynBio Canada as part of the Biodigital Convergence Webinar Series. This panel discussion will examine engineering biology-driven manufacturing opportunities from an international perspective. Many leading G20 jurisdictions already invest significantly in engineering biology through public-private partnerships and industry. This panel will explore initiatives and strategies in the U.S., the UK, and Canada.
Dr.Doug Friedman, CEO, BioMADE & EBRC, USA Pari Johnston, VP, Genome Canada Dr.Kirk Malone, Director of Commercialization, UK Future Biomanufacturing Research Hub (Future BRH), UK Dr.Renee Wegrzyn, VP Business Development, Ginkgo Bioworks, USA Dr. Aaron Dulgar-Tulloch, Global Head of Research and Development, Director of Cell and Gene Therapy, Cytiva (formerly GE Life Sciences), Canada Dr.Bettina Hamelin, CEO, Ontario Genomics (Moderator)
Discussion topics include:
The biomanufacturing opportunities and challenges across jurisdictions
The impact on and opportunities for traditional economic sectors and industries
The convergence of technologies that enable innovation, commercialization, job creation, and economic growth
Opportunities for international collaboration
The impact of the pandemic on local supply chains
The power of biomanufacturing and engineering biology to address climate change and a greener economy through low-carbon emissions